Quickly read this. Brilliant news & also for CDx indication. I’m not quoting, but DXB ASX are using PromarkerD in clinical trials at present for FSGS & DKD (umbrella CKD). The collaboration between PIQ & DXB has been long standing. There may be some data sharing there too, whatever is the best outcome for patients & ethics. Janssen is our biggest hope. GLTAH
Ann: US patent for identifying drugs for abnormal kidney function, page-4
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
65.5¢ |
Change
-0.015(2.24%) |
Mkt cap ! $85.15M | |||
| Open | High | Low | Value | Volume |
| 67.0¢ | 67.0¢ | 65.0¢ | $46.90K | 70.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 45287 | 65.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 68.0¢ | 5000 | 1 |
View Market Depth
| Last trade - 15.48pm 22/11/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |
